## **Core Concept**
Aromatase inhibitors are a class of drugs used in the treatment of breast cancer, particularly in hormone receptor-positive cases. They work by inhibiting the aromatase enzyme, which is responsible for converting androgens into estrogens. By reducing estrogen levels, these drugs help slow the growth of hormone receptor-positive breast tumors.

## **Why the Correct Answer is Right**
The correct answer, **Letrozole**, is an aromatase inhibitor used in the treatment of breast cancer. It works by selectively and reversibly inhibiting the aromatase enzyme, which leads to a decrease in estrogen production. This mechanism is crucial in the management of hormone receptor-positive breast cancer, as it deprives the tumor cells of the estrogen they need to grow.

## **Why Each Wrong Option is Incorrect**
- **Option A: Tamoxifen** is a selective estrogen receptor modulator (SERM), not an aromatase inhibitor. It works by binding to estrogen receptors on tumor cells, thereby blocking the effects of estrogen.
- **Option B: Methotrexate** is an antifolate drug used in chemotherapy. It works by inhibiting dihydrofolate reductase, an enzyme important for DNA synthesis and cell division, and is not related to aromatase inhibition.
- **Option D: Mifepristone** is an anti-progestin used primarily for medical abortion and in the management of Cushing's syndrome. It does not act as an aromatase inhibitor.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that aromatase inhibitors like **Letrozole** are particularly useful in postmenopausal women with hormone receptor-positive breast cancer, as these patients often have higher levels of aromatase activity. A classic clinical scenario where aromatase inhibitors are preferred over SERMs like tamoxifen is in the treatment of postmenopausal women due to their favorable side effect profile and efficacy.

## **Correct Answer: C. Letrozole**